Government urged to work more closely with cancer community

The Cancer Drugs Alliance has welcomed tonight’s announcement in the Federal Government Budget, that it will invest $1.6bn in listing new ...

Read more →

Submissions published for review of authority required PBS listings

Public submissions to the post-market review of authority required PBS listings closed on Wednesday, 8 October 2014. The public submissions ...

Read more →

Petition calls on Roche to cut breast cancer drug price

A British-led petition signed by 29,000 people has demanded that Switzerland's Roche, the world's biggest maker of cancer medicines, cut ...

Read more →

Applications sought for Consumer Advisory Committee

PHARMAC is seeking three new people for its Consumer Advisory Committee. ...

Read more →

Humira is now available for Canadian children living with severely active Crohn's Disease

[:content [\A \b \b \V \i \e \space \h \a \s \space \a \n \n \o \u \n \c \e \d \space \t \h \a \t \space \H \e \a \l \t \h \space \C \a \n \a \d \a \space \h \a \s \space \a \p \p \r \o \v \e \d \space \H \u \m \i \r \a \  \( \a \d \a \l \i \m \u \m \a \b \) \space \f \o \r \space \r \e \d \u \c \i \n \g \space \s \i \g \n \s \space \a \n \d \space \s \y \m \p \t \o \m \s \space \a \n \d \space \i \n \d \u \c \i \n \g \space \a \n \d \space \m \a \i \n \t \a \i \n \i \n \g \space \c \l \i \n \i \c \a \l \space \r \e \m \i \s \s \i \o \n " ..."]]
Read more →

Pharmacy agreement offers pills with a sugar coating

The new pharmacy agreement means consumers overall will pay billions of dollars more for prescribed medicines over the next five ...

Read more →

New treatment funded for severe gout

Patients with severe gout will soon have a new treatment option as PHARMAC will be funding febuxostat (Adenuric) from 1 ...

Read more →

Lucentis (ranibizumab) approved by Health Canada to treat vision loss resulting from choroidal neovascularization in pathologic myopia

Novartis Pharmaceuticals Canada Inc. announced today that Lucentis (ranibizumab), the treatment for several major causes of vision loss, has been approved ...

Read more →

PBAC stakeholder meeting - Nitisinone for tyrosinaemia type 1 (February 2015)

A stakeholder meeting was held on 4 February 2015 to discuss issues related to a recent submission to the PBAC ...

Read more →

Nexavar (sorafenib tablets) now approved in Canada for the treatment of differentiated thyroid cancer

Bayer Inc. is pleased to announce the Health Canada approval of Nexavar for the treatment of patients with locally advanced ...

Read more →

NICE publishes evidence summary on eculizumab (Soliris) for treating rare kidney condition

NICE has completed a rapid evidence summary on the off-label use of eculizumab (Soliris, Alexion Pharma UK) for managing dense ...

Read more →

Manitoba adds Kadcyla to the provincial formulary for the treatment of HER2-positive metastatic breast cancer

Women with HER2-positive metastatic breast cancer in Manitoba will now be able to access a new treatment option through CancerCare Manitoba.  The ...

Read more →

Dolutegravir sodium with abacavir sulphate and lamivudine: significant additional benefits for treatment-naïve adults with HIV

The fixed dose combination dolutegravir sodium with abacavir  sulfate and lamivudine (trade name Triumeq) has been approved since September 2014 for use by ...

Read more →

Recently added forthcoming submissions

[:content [\B \e \l \o \w \space \i \s \space \a \space \l \i \s \t \space \o \f \space \f \o \r \t \h \c \o \m \i \n \g \space \s \u \b \m \i \s \s \i \o \n \s \space \t \h \a \t \space \h \a \v \e \space \r \e \c \e \n \t \l \y \space \b \e \e \n \space \a \d \d \e \d \space \t \o \space \t \h \e \space \S \M \C \' \s \space \w \o \r \k \  \p \r \o \g \r \a \m \m \e \. " ..."]]
Read more →

ABPI responds to Labour’s plan to create Cancer Treatment Fund

ABPI Chief Executive, Stephen Whitehead, comments on the announcement by the Shadow Secretary of State for Health, Andy Burnham MP, ...

Read more →